{"title":"抗新城疫重组疫苗:当前趋势和研究议程","authors":"A. Shahriari, M. Habibi","doi":"10.52547/vacres.8.1.92","DOIUrl":null,"url":null,"abstract":"its causative the basics of producing recombinant vaccines and production platforms are protein or an 8-amino acid epitope of HN protein. Protein extensions including F, HN and HN2 (double HN replication)","PeriodicalId":52727,"journal":{"name":"Vaccine Research","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Recombinant vaccines against Newcastle Disease: current trends and research agenda\",\"authors\":\"A. Shahriari, M. Habibi\",\"doi\":\"10.52547/vacres.8.1.92\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"its causative the basics of producing recombinant vaccines and production platforms are protein or an 8-amino acid epitope of HN protein. Protein extensions including F, HN and HN2 (double HN replication)\",\"PeriodicalId\":52727,\"journal\":{\"name\":\"Vaccine Research\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52547/vacres.8.1.92\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52547/vacres.8.1.92","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Recombinant vaccines against Newcastle Disease: current trends and research agenda
its causative the basics of producing recombinant vaccines and production platforms are protein or an 8-amino acid epitope of HN protein. Protein extensions including F, HN and HN2 (double HN replication)